Phionah Tushabe

Phionah Tushabe

Auto-generated profile, based on publicly available information

Phionah Tushabe

Uganda Virus Research Institute, Entebbe, Uganda

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Emerging Infectious Diseases
Verified
Journal Article
Closed access
DBDaniel Lule Bugembe
Daniel Lule Bugembe
JKJohn Kayiwa
John Kayiwa
MPMy V.T. Phan
My V.T. Phan
PTPhiona Tushabe
Phiona Tushabe
SBStephen Balinandi
Stephen Balinandi
MCMatthew Cotten
Matthew Cotten
We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an important baseline for tracking any further transmission of the virus throughout the country and region.

4 April 2014 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
PNProssy Namuwulya
Prossy Namuwulya
EAEmily Abernathy
Emily Abernathy
HBHenry Bukenya
Henry Bukenya
JBJosephine Bwogi
Josephine Bwogi
PTPhionah Tushabe
Phionah Tushabe
BBBarnabas Bakamutumaho
Barnabas Bakamutumaho

2 January 2016 in Archives of Virology
Verified
Journal Article
Open access
PDF file
JBJosephine Bwogi
Josephine Bwogi
SMSamuel Malamba
Samuel Malamba
BKBrian Kigozi
Brian Kigozi
PNProssy Namuwulya
Prossy Namuwulya
PTPhionah Tushabe
Phionah Tushabe
CKCharles Karamagi
Charles Karamagi
A cross-sectional study was undertaken during 2012-2013 to determine the prevalence, strains and factors associated with rotavirus infection among under-5-year-old children hospitalized with acute diarrhea in Uganda. Rotaviruses were detected in 37 % (263/712) of the children. The most prevalent strains were G9P[8] (27 %, 55/204) and G12P[4] (18.6 %, 38/204). Mixed infections were detected in 22.5 % (46/204) of the children. The study suggests that consumption of raw vegetables (OR = 1.45, 95 % CI = 1.03-2.03) and family ownership of dogs (OR = 1.9, 95 % CI = 1.04-3.75) increases the risk of rotavirus infection. The study findings will be used to assess the impact of RV vaccination in Uganda.

9 October 2019 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
PTPhionah Tushabe
Phionah Tushabe
JBJosephine Bwogi
Josephine Bwogi
EAEmily Abernathy
Emily Abernathy
MBMolly Birungi
Molly Birungi
JEJames P. Eliku
James P. Eliku
BBBarnabas Bakamutumaho
Barnabas Bakamutumaho
Rubella virus causes a mild disease; however, infection during the first trimester of pregnancy may lead to congenital rubella syndrome (CRS) in over 80% of affected pregnancies. Vaccination is recommended and has been shown to effectively reduce CRS incidence. Uganda plans to introduce routine rubella vaccination in 2019. The World Health Organization recommends assessing the disease burden and obtaining the baseline molecular virological data before vaccine introduction. Sera collected during case‐based measles surveillance from January 2005 to July 2018 were tested for rubella immunoglobulin M (IgM) antibodies. Sera from confirmed rubella outbreaks from January 2012 to August 2017 were screened using real‐time reverse‐transcription polymerase chain reaction (RT‐PCR); for positive samples, a region within the E1 glycoprotein coding region was amplified and sequenced. Of the 23 196 suspected measles cases serologically tested in parallel for measles and rubella, 5334 (23%) were rubella IgM‐positive of which 2710 (50.8%) cases were females with 2609 (96.3%) below 15 years of age. Rubella IgM‐positive cases were distributed throughout the country and the highest number was detected in April, August, and November. Eighteen (18%) of the 100 sera screened were real‐time RT‐PCR‐positive of which eight (44.4%) were successfully sequenced and genotypes 1G and 2B were identified. This study reports on the seroprevalence and molecular epidemiology of rubella. Increased knowledge of former and current rubella viruses circulating in Uganda will enhance efforts to monitor the impact of vaccination as Uganda moves toward control and elimination of rubella and CRS.

10 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJosephine Bwogi
Josephine Bwogi
TLTom Lutalo
Tom Lutalo
PTPhionah Tushabe
Phionah Tushabe
HBHenry Bukenya
Henry Bukenya
JEJames Peter Eliku
James Peter Eliku
UTUvri -Covid 19 Technical Team
Uvri -Covid 19 Technical Team
Objective: The objective of this study was to evaluate the performance of seven antigen rapid diagnostic tests (Ag RDTs) in a clinical setting to identify those that could be recommended for use in the diagnosis of SARS-CoV-2 infection in Uganda. Methods: This was a cross-sectional prospective study. Nasopharyngeal swabs were collected consecutively from COVID-19 PCR positive and COVID-19 PCR negative participants at isolation centers and points of entry, and tested with the SARS-CoV-2 Ag RDTs. Test sensitivity and specificity were generated by comparing results against qRT-PCR results (Berlin Protocol) at a cycle threshold (Ct) cut-off of ≤39. Sensitivity was also calculated at Ct cut-offs ≤29 and ≤33. Results: None of the Ag RDTs had a sensitivity of ≥80% at Ct cut-off values ≤33 and ≤39. Two kits, Panbio™ COVID-19 Ag and VivaDiag™ SARS-CoV-2 Ag had a sensitivity of ≥80% at a Ct cut-off value of ≤29. Four kits: BIOCREDIT COVID -19 Ag, COVID-19 Ag Respi-Strip, MEDsan® SARS-CoV-2 Antigen Rapid Test and Panbio™ COVID-19 Ag Rapid Test had a specificity of ≥97%. Conclusions: This evaluation identified one Ag RDT, Panbio™ COVID-19 Ag with a performance at high viral load (Ct value ≤29) reaching that recommended by WHO. This kit was recommended for screening of patients with COVID -19-like symptoms presenting at health facilities.

15 April 2023 in Archives of Virology
Verified
Journal Article
Open access
PDF file
PTPhionah Tushabe
Phionah Tushabe
JBJosephine Bwogi
Josephine Bwogi
JEJames Peter Eliku
James Peter Eliku
FAFrancis Aine
Francis Aine
MBMolly Birungi
Molly Birungi
CBCharles R. Byabamazima
Charles R. Byabamazima
The success of the global polio eradication initiative is threatened by the genetic instability of the oral polio vaccine, which can result in the emergence of pathogenic vaccine-derived polioviruses following prolonged replication in the guts of individuals with primary immune deficiencies or in communities with low vaccination coverage. Through environmental surveillance, circulating vaccine-derived poliovirus type 2 was detected in Uganda in the absence of detection by acute flaccid paralysis (AFP) surveillance. This underscores the sensitivity of environmental surveillance and emphasizes its usefulness in supplementing AFP surveillance for poliovirus infections in the race towards global polio eradication.